Copyright Reports & Markets. All rights reserved.

Global Vaccine Administration Market Growth (Status and Outlook) 2021-2026

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Vaccine Administration Market Size 2016-2026
    • 2.1.2 Vaccine Administration Market Size CAGR by Region 2020 VS 2021 VS 2026
  • 2.2 Vaccine Administration Segment by Type
    • 2.2.1 Viral Diseases
    • 2.2.2 Viral Diseases
  • 2.3 Vaccine Administration Market Size by Type
    • 2.3.1 Global Vaccine Administration Market Size CAGR by Type
    • 2.3.2 Global Vaccine Administration Market Size Market Share by Type (2016-2021)
  • 2.4 Vaccine Administration Segment by Application
    • 2.4.1 Paediatrics
    • 2.4.2 Adults
  • 2.5 Vaccine Administration Market Size by Application
    • 2.5.1 Global Vaccine Administration Market Size CAGR by Application
    • 2.5.2 Global Vaccine Administration Market Size Market Share by Application (2016-2021)

3 Vaccine Administration Market Size by Players

  • 3.1 Vaccine Administration Market Size Market Share by Players
    • 3.1.1 Global Vaccine Administration Revenue by Players (2019-2021E)
    • 3.1.2 Global Vaccine Administration Revenue Market Share by Players (2019-2021E)
  • 3.2 Global Vaccine Administration Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Vaccine Administration by Regions

  • 4.1 Vaccine Administration Market Size by Regions (2016-2021)
  • 4.2 Americas Vaccine Administration Market Size Growth (2016-2021)
  • 4.3 APAC Vaccine Administration Market Size Growth (2016-2021)
  • 4.4 Europe Vaccine Administration Market Size Growth (2016-2021)
  • 4.5 Middle East & Africa Vaccine Administration Market Size Growth (2016-2021)

5 Americas

  • 5.1 Americas Vaccine Administration Market Size by Country (2016-2021)
  • 5.2 Americas Vaccine Administration Market Size by Type (2016-2021)
  • 5.3 Americas Vaccine Administration Market Size by Application (2016-2021)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Vaccine Administration Market Size by Region (2016-2021)
  • 6.2 APAC Vaccine Administration Market Size by Type (2016-2021)
  • 6.3 APAC Vaccine Administration Market Size by Application (2016-2021)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Vaccine Administration by Country (2016-2021)
  • 7.2 Europe Vaccine Administration Market Size by Type (2016-2021)
  • 7.3 Europe Vaccine Administration Market Size by Application (2016-2021)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Vaccine Administration by Region (2016-2021)
  • 8.2 Middle East & Africa Vaccine Administration Market Size by Type (2016-2021)
  • 8.3 Middle East & Africa Vaccine Administration Market Size by Application (2016-2021)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers and Impact
    • 9.1.1 Growing Demand from Key Regions
    • 9.1.2 Growing Demand from Key Applications and Potential Industries
  • 9.2 Market Challenges and Impact
  • 9.3 Market Trends

10 Global Vaccine Administration Market Forecast

  • 10.1 Global Vaccine Administration Forecast by Regions (2021-2026)
    • 10.1.1 Global Vaccine Administration Forecast by Regions (2021-2026)
    • 10.1.2 Americas Vaccine Administration Forecast
    • 10.1.3 APAC Vaccine Administration Forecast
    • 10.1.4 Europe Vaccine Administration Forecast
    • 10.1.5 Middle East & Africa Vaccine Administration Forecast
  • 10.2 Americas Vaccine Administration Forecast by Countries (2021-2026)
    • 10.2.1 United States Vaccine Administration Market Forecast
    • 10.2.2 Canada Vaccine Administration Market Forecast
    • 10.2.3 Mexico Vaccine Administration Market Forecast
    • 10.2.4 Brazil Vaccine Administration Market Forecast
  • 10.3 APAC Vaccine Administration Forecast by Region (2021-2026)
    • 10.3.1 China Vaccine Administration Market Forecast
    • 10.3.2 Japan Vaccine Administration Market Forecast
    • 10.3.3 Korea Vaccine Administration Market Forecast
    • 10.3.4 Southeast Asia Vaccine Administration Market Forecast
    • 10.3.5 India Vaccine Administration Market Forecast
    • 10.3.6 Australia Vaccine Administration Market Forecast
  • 10.4 Europe Vaccine Administration Forecast by Country (2021-2026)
    • 10.4.1 Germany Vaccine Administration Market Forecast
    • 10.4.2 France Vaccine Administration Market Forecast
    • 10.4.3 UK Vaccine Administration Market Forecast
    • 10.4.4 Italy Vaccine Administration Market Forecast
    • 10.4.5 Russia Vaccine Administration Market Forecast
  • 10.5 Middle East & Africa Vaccine Administration Forecast by Region (2021-2026)
    • 10.5.1 Egypt Vaccine Administration Market Forecast
    • 10.5.2 South Africa Vaccine Administration Market Forecast
    • 10.5.3 Israel Vaccine Administration Market Forecast
    • 10.5.4 Turkey Vaccine Administration Market Forecast
    • 10.5.5 GCC Countries Vaccine Administration Market Forecast
  • 10.6 Global Vaccine Administration Forecast by Type (2021-2026)
  • 10.7 Global Vaccine Administration Forecast by Application (2021-2026)

11 Key Players Analysis

  • 11.1 Pfizer
    • 11.1.1 Pfizer Company Information
    • 11.1.2 Pfizer Vaccine Administration Product Offered
    • 11.1.3 Pfizer Vaccine Administration Revenue, Gross Margin and Market Share (2019-2021)
    • 11.1.4 Pfizer Main Business Overview
    • 11.1.5 Pfizer Latest Developments
  • 11.2 AstraZeneca
    • 11.2.1 AstraZeneca Company Information
    • 11.2.2 AstraZeneca Vaccine Administration Product Offered
    • 11.2.3 AstraZeneca Vaccine Administration Revenue, Gross Margin and Market Share (2019-2021)
    • 11.2.4 AstraZeneca Main Business Overview
    • 11.2.5 AstraZeneca Latest Developments
  • 11.3 Sanofi Aventis
    • 11.3.1 Sanofi Aventis Company Information
    • 11.3.2 Sanofi Aventis Vaccine Administration Product Offered
    • 11.3.3 Sanofi Aventis Vaccine Administration Revenue, Gross Margin and Market Share (2019-2021)
    • 11.3.4 Sanofi Aventis Main Business Overview
    • 11.3.5 Sanofi Aventis Latest Developments
  • 11.4 Merck
    • 11.4.1 Merck Company Information
    • 11.4.2 Merck Vaccine Administration Product Offered
    • 11.4.3 Merck Vaccine Administration Revenue, Gross Margin and Market Share (2019-2021)
    • 11.4.4 Merck Main Business Overview
    • 11.4.5 Merck Latest Developments
  • 11.5 GlaxoSmithKline
    • 11.5.1 GlaxoSmithKline Company Information
    • 11.5.2 GlaxoSmithKline Vaccine Administration Product Offered
    • 11.5.3 GlaxoSmithKline Vaccine Administration Revenue, Gross Margin and Market Share (2019-2021)
    • 11.5.4 GlaxoSmithKline Main Business Overview
    • 11.5.5 GlaxoSmithKline Latest Developments
  • 11.6 Emergent BioSolutions
    • 11.6.1 Emergent BioSolutions Company Information
    • 11.6.2 Emergent BioSolutions Vaccine Administration Product Offered
    • 11.6.3 Emergent BioSolutions Vaccine Administration Revenue, Gross Margin and Market Share (2019-2021)
    • 11.6.4 Emergent BioSolutions Main Business Overview
    • 11.6.5 Emergent BioSolutions Latest Developments
  • 11.7 Johnson & Johnson
    • 11.7.1 Johnson & Johnson Company Information
    • 11.7.2 Johnson & Johnson Vaccine Administration Product Offered
    • 11.7.3 Johnson & Johnson Vaccine Administration Revenue, Gross Margin and Market Share (2019-2021)
    • 11.7.4 Johnson & Johnson Main Business Overview
    • 11.7.5 Johnson & Johnson Latest Developments
  • 11.8 CSL Limited
    • 11.8.1 CSL Limited Company Information
    • 11.8.2 CSL Limited Vaccine Administration Product Offered
    • 11.8.3 CSL Limited Vaccine Administration Revenue, Gross Margin and Market Share (2019-2021)
    • 11.8.4 CSL Limited Main Business Overview
    • 11.8.5 CSL Limited Latest Developments
  • 11.9 Serum Institute of India
    • 11.9.1 Serum Institute of India Company Information
    • 11.9.2 Serum Institute of India Vaccine Administration Product Offered
    • 11.9.3 Serum Institute of India Vaccine Administration Revenue, Gross Margin and Market Share (2019-2021)
    • 11.9.4 Serum Institute of India Main Business Overview
    • 11.9.5 Serum Institute of India Latest Developments
  • 11.10 Bharat Biotech
    • 11.10.1 Bharat Biotech Company Information
    • 11.10.2 Bharat Biotech Vaccine Administration Product Offered
    • 11.10.3 Bharat Biotech Vaccine Administration Revenue, Gross Margin and Market Share (2019-2021)
    • 11.10.4 Bharat Biotech Main Business Overview
    • 11.10.5 Bharat Biotech Latest Developments

11. VBI Vaccines

  • 11.11.1 VBI Vaccines Company Information
  • 11.11.2 VBI Vaccines Vaccine Administration Product Offered
  • 11.11.3 VBI Vaccines Vaccine Administration Revenue, Gross Margin and Market Share (2019-2021)
  • 11.11.4 VBI Vaccines Main Business Overview
  • 11.11.5 VBI Vaccines Latest Developments
  • 11.12 Sinovac Biotech
    • 11.12.1 Sinovac Biotech Company Information
    • 11.12.2 Sinovac Biotech Vaccine Administration Product Offered
    • 11.12.3 Sinovac Biotech Vaccine Administration Revenue, Gross Margin and Market Share (2019-2021)
    • 11.12.4 Sinovac Biotech Main Business Overview
    • 11.12.5 Sinovac Biotech Latest Developments

    • 12 Research Findings and Conclusion

    According to this latest study, the 2021 growth of Vaccine Administration will have significant change from previous year. By the most conservative estimates of global Vaccine Administration market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Vaccine Administration market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

    This report presents a comprehensive overview, market shares, and growth opportunities of Vaccine Administration market by product type, application, key players and key regions and countries.

    Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
    Viral Diseases
    Bacterial Diseases

    Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
    Paediatrics
    Adults

    This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
    United States
    Canada
    Mexico
    Brazil
    APAC
    China
    Japan
    Korea
    Southeast Asia
    India
    Australia
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Middle East & Africa
    Egypt
    South Africa
    Israel
    Turkey
    GCC Countries

    The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
    Pfizer
    AstraZeneca
    Sanofi Aventis
    Merck
    GlaxoSmithKline
    Emergent BioSolutions
    Johnson & Johnson
    CSL Limited
    Serum Institute of India
    Bharat Biotech
    VBI Vaccines
    Sinovac Biotech
    Buy now